Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RO7049389 and Pitavastatin PK Interaction Study
NCT03717064Phase 1Completed
- Sponsor
- Roche
- Start
- Nov 2018
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of linvencorvir in Chronic Hepatitis B (CHB), sponsored by Roche. Primary endpoints: Maximum Plasma Concentration of Pitavastatin, Area Under the Plasma Concentration Versus Time Curve from Time 0 to Infinity of Pitavastatin and 4 more. Started Nov 2018; status: completed.
02
Drugs
linvencorvir
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT03717064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03717064.